Mario Durán‐Prado

Identification and Characterization of Two Novel Truncated but Functional Isoforms of the Somatostatin Receptor Subtype 5 Differentially Present in Pituitary Tumors

Mario Durán‐Prado, Manuel D. Gahete, Antonio J. Martínez‐Fuentes et al. · The Journal of Clinical Endocrinology & Metabolism · 2009 · 141 citations

Medicine, Endocrinology, Molecular Biology +15

Graphene and graphene oxide induce ROS production in human HaCaT skin keratinocytes: the role of xanthine oxidase and NADH dehydrogenase

Marco Pelin, Laura Fusco, Cristina Martín et al. · Nanoscale · 2018 · 127 citations · Full text

Life Sciences, Biochemistry, Dermatology +16

Three Novel Missense Mutations within the LHX4 Gene Are Associated with Variable Pituitary Hormone Deficiencies

Roland Pfaeffle, Chad S. Hunter, Jesse J. Savage et al. · The Journal of Clinical Endocrinology & Metabolism · 2007 · 117 citations · Full text

Medicine, Endocrinology, Genetics +17

A Potential Inhibitory Role for the New Truncated Variant of Somatostatin Receptor 5, sst5TMD4, in Pituitary Adenomas Poorly Responsive to Somatostatin Analogs

Mario Durán‐Prado, Alexandru Saveanu, Raúl M. Luque et al. · The Journal of Clinical Endocrinology & Metabolism · 2010 · 95 citations

Medicine, Endocrinology, Oncology +17

Expression of Somatostatin, Cortistatin, and Their Receptors, as well as Dopamine Receptors, but not of Neprilysin, are Reduced in the Temporal Lobe of Alzheimer's Disease Patients

Manuel D. Gahete, Alicia Rubio, Mario Durán‐Prado et al. · Journal of Alzheimer s Disease · 2010 · 76 citations

Life Sciences, Neurology, Neuroscience +17